Skip to main content
. 2021 Aug;13(8):5016–5034. doi: 10.21037/jtd-21-935

Figure 10.

Figure 10

The risk score was significantly correlated with LUAD immune cell markers. (A) PVR; (B) CD276; (C) CXCL5; (D) CXCL8; (E) CCL26; (F) CCL7; (G) CCR7; (H) CD48; (I) TNFRSF13C; (J) HLA-DOB; (K) CCL19; (L) HLA-DMA. LUAD, lung adenocarcinoma.